Cargando…
Chemical Proteomic Analysis Reveals the Drugability of the Kinome of Trypanosoma brucei
[Image: see text] The protozoan parasite Trypanosoma brucei is the causative agent of African sleeping sickness, and there is an urgent unmet need for improved treatments. Parasite protein kinases are attractive drug targets, provided that the host and parasite kinomes are sufficiently divergent to...
Autores principales: | Urbaniak, Michael D., Mathieson, Toby, Bantscheff, Marcus, Eberhard, Dirk, Grimaldi, Raffaella, Miranda-Saavedra, Diego, Wyatt, Paul, Ferguson, Michael A. J., Frearson, Julie, Drewes, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621575/ https://www.ncbi.nlm.nih.gov/pubmed/22908928 http://dx.doi.org/10.1021/cb300326z |
Ejemplares similares
-
Unusual features and localization of the membrane kinome of Trypanosoma brucei
por: Jensen, Bryan C., et al.
Publicado: (2021) -
Nuclear DBF-2-related Kinases Are Essential Regulators of Cytokinesis in Bloodstream Stage Trypanosoma brucei
por: Ma, Jiangtao, et al.
Publicado: (2010) -
The Design and Synthesis of
Potent and Selective Inhibitors
of Trypanosoma brucei Glycogen Synthase
Kinase 3 for the Treatment of Human African Trypanosomiasis
por: Urich, Robert, et al.
Publicado: (2014) -
From On-Target to Off-Target Activity: Identification and Optimisation of Trypanosoma brucei GSK3 Inhibitors and Their Characterisation as Anti-Trypanosoma brucei Drug Discovery Lead Molecules
por: Woodland, Andrew, et al.
Publicado: (2013) -
Comparative SILAC Proteomic Analysis of Trypanosoma brucei Bloodstream and Procyclic Lifecycle Stages
por: Urbaniak, Michael D., et al.
Publicado: (2012)